NCT07754656

Brief Summary

The goal of this controlled single centre RCT is to compare frequency rates concerning return of spontaneous circulation (ROSC) in prehospital cardiac arrest. Two different algorithms (control-and interventiongroup) of advanced cardiac life support will be used to treat patients. In patients over 18 years suffering from cardiac arrest. The main question aims to answer if the frequency of ROSC differs between the groups receiving either the new Advanced Life Support (ALS) algorithm, or standard treatment. Researchers will compare the new algorithm to the standard care algorithm to see if there is a difference . Participants will be randomized to treatment on scene. The controlgroup will receive ALS standard treatment as performed in local protocols. The intervention group will receive a modified treatment including:

  • thorax compression via mechanical device (LUCAS 3)
  • head up Cardiopulmonary Resuscitation (cpr)
  • use of an impendance threshold device (ITD) module
  • arterial line placement
  • continuous epinephrin infusion via infusion pump
  • double sequence defibrillation

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
216

participants targeted

Target at P75+ for not_applicable

Timeline
32mo left

Started Jan 2026

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress17%
Jan 2026Mar 2029

Study Start

First participant enrolled

January 28, 2026

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

May 8, 2026

Completed
3 months until next milestone

First Posted

Study publicly available on registry

August 10, 2026

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 28, 2029

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 28, 2029

Last Updated

August 10, 2026

Status Verified

August 1, 2026

Enrollment Period

3 years

First QC Date

May 8, 2026

Last Update Submit

August 4, 2026

Conditions

Keywords

cardiac arresthead up cprcontinuous adrenalin infusionmechanical thorax compressionITDarterial linediastolic blood pressureROSCOHCA

Outcome Measures

Primary Outcomes (1)

  • ROSC

    frequency of ROSC in the study cohort

    one minute

Secondary Outcomes (3)

  • Time to ROSC

    Periprocedural: from enrollement to ROSC or Termination of Resuscitation (TOR)

  • CO2

    Periprocedural: from enrollement to ROSC orTOR

  • descriptive data

    Periprocedural: during study intervention

Study Arms (2)

ALS ERC 2025

ACTIVE COMPARATOR
Procedure: ERC ALS 2025

adapted CPR algorithm

EXPERIMENTAL

* thorax compression via mechanical device (LUCAS 3) * head up cpr * use of an ITD module * arterial line placement * continuous epinephrin infusion via infusion pump * double sequence defibrillation

Procedure: aCPR algorithm

Interventions

* thorax compression via mechanical device (LUCAS 3) * head up cpr * use of an ITD module * arterial line placement * continuous epinephrin infusion via infusion pump * double sequence defibrillation

adapted CPR algorithm
ERC ALS 2025PROCEDURE

Placement of an IV line, placement of a supraglottic airway device or endotracheal intubation. Optional use of an intraosseus acces

ALS ERC 2025

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age\> 18 years
  • time of resuscitation \<21 minutes when enrollement starts

You may not qualify if:

  • obvious pregnancy
  • contraindications for the use of Lucas 3
  • time of resuscitation \>21 minutes and etCO2 \<15 mmHg upon arrival of the emergency physician on scene

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kepler University Hospital

Linz, Upper Austria, 4020, Austria

RECRUITING

MeSH Terms

Conditions

Heart Arrest

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Study Officials

  • Jens Meier, Univ. Prof.

    Kepler University Hospital / Johannes Kepler University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 8, 2026

First Posted

August 10, 2026

Study Start

January 28, 2026

Primary Completion (Estimated)

January 28, 2029

Study Completion (Estimated)

March 28, 2029

Last Updated

August 10, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Deidentified participant data utilized in this study can be made available upon reasonable request to the corresponding author. Access to the data will be subject to approval by institutional and ethical considerations.

Locations